AR064832A1 - Utilizacion de ivabradina para la obtencion de medicamentos destinados al tratamiento de la disfuncion endotelial - Google Patents
Utilizacion de ivabradina para la obtencion de medicamentos destinados al tratamiento de la disfuncion endotelialInfo
- Publication number
- AR064832A1 AR064832A1 ARP080100090A ARP080100090A AR064832A1 AR 064832 A1 AR064832 A1 AR 064832A1 AR P080100090 A ARP080100090 A AR P080100090A AR P080100090 A ARP080100090 A AR P080100090A AR 064832 A1 AR064832 A1 AR 064832A1
- Authority
- AR
- Argentina
- Prior art keywords
- ivabradine
- treatment
- dysfunction
- endotelial
- medicines
- Prior art date
Links
Classifications
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/33—Heterocyclic compounds
- A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
- A61K31/55—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having seven-membered rings, e.g. azelastine, pentylenetetrazole
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P17/00—Drugs for dermatological disorders
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
- A61P25/28—Drugs for disorders of the nervous system for treating neurodegenerative disorders of the central nervous system, e.g. nootropic agents, cognition enhancers, drugs for treating Alzheimer's disease or other forms of dementia
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P3/00—Drugs for disorders of the metabolism
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P3/00—Drugs for disorders of the metabolism
- A61P3/06—Antihyperlipidemics
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P3/00—Drugs for disorders of the metabolism
- A61P3/08—Drugs for disorders of the metabolism for glucose homeostasis
- A61P3/10—Drugs for disorders of the metabolism for glucose homeostasis for hyperglycaemia, e.g. antidiabetics
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P9/00—Drugs for disorders of the cardiovascular system
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P9/00—Drugs for disorders of the cardiovascular system
- A61P9/04—Inotropic agents, i.e. stimulants of cardiac contraction; Drugs for heart failure
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P9/00—Drugs for disorders of the cardiovascular system
- A61P9/06—Antiarrhythmics
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P9/00—Drugs for disorders of the cardiovascular system
- A61P9/08—Vasodilators for multiple indications
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P9/00—Drugs for disorders of the cardiovascular system
- A61P9/10—Drugs for disorders of the cardiovascular system for treating ischaemic or atherosclerotic diseases, e.g. antianginal drugs, coronary vasodilators, drugs for myocardial infarction, retinopathy, cerebrovascula insufficiency, renal arteriosclerosis
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P9/00—Drugs for disorders of the cardiovascular system
- A61P9/12—Antihypertensives
Landscapes
- Health & Medical Sciences (AREA)
- Veterinary Medicine (AREA)
- Pharmacology & Pharmacy (AREA)
- Bioinformatics & Cheminformatics (AREA)
- Engineering & Computer Science (AREA)
- Chemical & Material Sciences (AREA)
- Public Health (AREA)
- General Health & Medical Sciences (AREA)
- Medicinal Chemistry (AREA)
- Animal Behavior & Ethology (AREA)
- Life Sciences & Earth Sciences (AREA)
- Chemical Kinetics & Catalysis (AREA)
- Organic Chemistry (AREA)
- Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
- General Chemical & Material Sciences (AREA)
- Cardiology (AREA)
- Heart & Thoracic Surgery (AREA)
- Diabetes (AREA)
- Hematology (AREA)
- Neurosurgery (AREA)
- Epidemiology (AREA)
- Obesity (AREA)
- Biomedical Technology (AREA)
- Neurology (AREA)
- Hospice & Palliative Care (AREA)
- Emergency Medicine (AREA)
- Psychiatry (AREA)
- Vascular Medicine (AREA)
- Endocrinology (AREA)
- Urology & Nephrology (AREA)
- Dermatology (AREA)
- Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
- Other In-Based Heterocyclic Compounds (AREA)
- Medicinal Preparation (AREA)
- Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
Abstract
Utilizacion de ivabradina o 3-{3-[{[(7S)-3,4-dimetoxibiciclo[4.2.0]octa-1,3,5-trien-7-il]-metil}-(metil)-amino]-propil} -7,8-dimetoxi-1,3,4,5-tetrahidro-2H-3-benzazepin-2-ona, de sus sales de adicion a un ácido aceptable farmacéuticamente y de sus hidratos, para la obtencion de un medicamento destinado al tratamiento de la disfuncion endotelial, y sus composiciones farmacéuticas.
Applications Claiming Priority (1)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| FR0700189A FR2911279B1 (fr) | 2007-01-11 | 2007-01-11 | Utilisation de l'ivabradine pour l'obtention de medicaments destines au traitement de la dysfonction endotheliale |
Publications (1)
| Publication Number | Publication Date |
|---|---|
| AR064832A1 true AR064832A1 (es) | 2009-04-29 |
Family
ID=38123876
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| ARP080100090A AR064832A1 (es) | 2007-01-11 | 2008-01-10 | Utilizacion de ivabradina para la obtencion de medicamentos destinados al tratamiento de la disfuncion endotelial |
Country Status (20)
| Country | Link |
|---|---|
| US (2) | US20080200450A1 (es) |
| EP (1) | EP1944031A1 (es) |
| JP (1) | JP2008169213A (es) |
| KR (2) | KR20080066613A (es) |
| CN (1) | CN101480398B (es) |
| AR (1) | AR064832A1 (es) |
| AU (1) | AU2008200123B2 (es) |
| BR (1) | BRPI0800001A2 (es) |
| CA (1) | CA2617363C (es) |
| EA (1) | EA015398B1 (es) |
| FR (1) | FR2911279B1 (es) |
| GE (1) | GEP20115158B (es) |
| MA (1) | MA29720B1 (es) |
| MX (1) | MX2008000023A (es) |
| MY (1) | MY148650A (es) |
| NZ (1) | NZ564997A (es) |
| SG (1) | SG144832A1 (es) |
| UA (1) | UA96574C2 (es) |
| WO (1) | WO2008099091A2 (es) |
| ZA (1) | ZA200800358B (es) |
Families Citing this family (4)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| FR2938194B1 (fr) * | 2008-11-07 | 2012-08-31 | Servier Lab | Utilisation de l'ivabradine comme agent de diagnostic dans la methode d'angiographie coronaire par tomodensitometrie multicoupe |
| FR2961105B1 (fr) * | 2010-06-15 | 2013-02-08 | Servier Lab | Utilisation de l'association d'un inhibiteur du courant if sinusal et d'un inhibiteur de l'enzyme de conversion de l'angiotensine pour le traitement de l'insuffisance cardiaque |
| CN102908327B (zh) * | 2011-08-05 | 2015-03-11 | 江苏恒瑞医药股份有限公司 | 伊伐布雷定或其可药用盐的缓释制剂 |
| GB201312386D0 (en) * | 2013-07-10 | 2013-08-21 | Isis Innovation | Pharmaceutical compounds |
Family Cites Families (4)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| FR2681862B1 (fr) | 1991-09-27 | 1993-11-12 | Adir Cie | Nouvelles (benzocycloalkyl)alkylamines, leur procede de preparation, et les compositions pharmaceutiques qui les contiennent. |
| BR0109966A (pt) * | 2000-04-12 | 2003-08-05 | Novartis Ag | Combinação de compostos orgânicos |
| FR2834896B1 (fr) * | 2002-01-23 | 2004-02-27 | Servier Lab | Composition pharmaceutique orodispersible d'ivabradine |
| FR2882553B1 (fr) * | 2005-02-28 | 2007-05-04 | Servier Lab | Forme cristalline beta du chlorhydrate de l'ivabradine, son procede de preparation, et les compositions pharmaceutiques qui la contiennent |
-
2007
- 2007-01-11 FR FR0700189A patent/FR2911279B1/fr not_active Expired - Fee Related
-
2008
- 2008-01-04 GE GEAP200810468A patent/GEP20115158B/en unknown
- 2008-01-04 UA UAA200800220A patent/UA96574C2/ru unknown
- 2008-01-07 MX MX2008000023A patent/MX2008000023A/es not_active Application Discontinuation
- 2008-01-07 MA MA30547A patent/MA29720B1/fr unknown
- 2008-01-08 MY MYPI20080032A patent/MY148650A/en unknown
- 2008-01-09 AU AU2008200123A patent/AU2008200123B2/en not_active Ceased
- 2008-01-10 WO PCT/FR2008/000027 patent/WO2008099091A2/fr not_active Ceased
- 2008-01-10 BR BRPI0800001-8A patent/BRPI0800001A2/pt not_active Application Discontinuation
- 2008-01-10 CA CA2617363A patent/CA2617363C/fr not_active Expired - Fee Related
- 2008-01-10 NZ NZ564997A patent/NZ564997A/en not_active IP Right Cessation
- 2008-01-10 AR ARP080100090A patent/AR064832A1/es not_active Application Discontinuation
- 2008-01-10 EP EP08290020A patent/EP1944031A1/fr not_active Ceased
- 2008-01-10 EA EA200800022A patent/EA015398B1/ru not_active IP Right Cessation
- 2008-01-11 CN CN2008100095665A patent/CN101480398B/zh not_active Expired - Fee Related
- 2008-01-11 US US12/008,437 patent/US20080200450A1/en not_active Abandoned
- 2008-01-11 SG SG200800298-2A patent/SG144832A1/en unknown
- 2008-01-11 JP JP2008003835A patent/JP2008169213A/ja active Pending
- 2008-01-11 KR KR1020080003504A patent/KR20080066613A/ko not_active Ceased
- 2008-01-11 ZA ZA200800358A patent/ZA200800358B/en unknown
-
2010
- 2010-08-30 KR KR1020100083962A patent/KR101359936B1/ko not_active Expired - Fee Related
-
2011
- 2011-07-21 US US13/136,033 patent/US20110288072A1/en not_active Abandoned
Also Published As
| Publication number | Publication date |
|---|---|
| AU2008200123A1 (en) | 2008-07-31 |
| CN101480398B (zh) | 2011-07-27 |
| MY148650A (en) | 2013-05-15 |
| NZ564997A (en) | 2009-09-25 |
| KR20100112540A (ko) | 2010-10-19 |
| ZA200800358B (en) | 2008-11-26 |
| EA200800022A2 (ru) | 2008-08-29 |
| FR2911279A1 (fr) | 2008-07-18 |
| EA015398B1 (ru) | 2011-08-30 |
| MX2008000023A (es) | 2009-02-23 |
| CA2617363C (fr) | 2012-12-04 |
| AU2008200123B2 (en) | 2012-08-16 |
| CN101480398A (zh) | 2009-07-15 |
| WO2008099091A2 (fr) | 2008-08-21 |
| GEP20115158B (en) | 2011-02-10 |
| US20110288072A1 (en) | 2011-11-24 |
| EP1944031A1 (fr) | 2008-07-16 |
| US20080200450A1 (en) | 2008-08-21 |
| HK1130686A1 (en) | 2010-01-08 |
| MA29720B1 (fr) | 2008-09-01 |
| KR20080066613A (ko) | 2008-07-16 |
| KR101359936B1 (ko) | 2014-02-10 |
| WO2008099091A3 (fr) | 2008-10-02 |
| SG144832A1 (en) | 2008-08-28 |
| JP2008169213A (ja) | 2008-07-24 |
| FR2911279B1 (fr) | 2009-03-06 |
| EA200800022A3 (ru) | 2008-12-30 |
| CA2617363A1 (fr) | 2008-07-11 |
| UA96574C2 (ru) | 2011-11-25 |
| BRPI0800001A2 (pt) | 2010-02-23 |
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| PL1598333T3 (pl) | Sposób syntezy (1S)-4,5-dimetoksy-1-(metyloaminometylo)benzocyklobutanu i jego soli addycyjnych, oraz zastosowanie do syntezy iwabradyny i jej soli addycyjnych z dopuszczalnym farmaceutycznie kwasem | |
| AR064832A1 (es) | Utilizacion de ivabradina para la obtencion de medicamentos destinados al tratamiento de la disfuncion endotelial | |
| MX2009014193A (es) | Preparacion farmaceutica solida que comprende benzazepinas y metodo de produccion de la misma. | |
| ZA200904316B (en) | Process for the synthesis of 7,8-dimethoxy-1,3-dihydro-2H-3-benzazepin-2-one, and application in the synthesis of ivabradine and addition salts thereof with a pharmaceutically acceptable acid | |
| HRP20110532T1 (hr) | Kombinacija inhibitora if struje sinusnog čvora i inhibitora enzima konverzije angiotenzina | |
| NZ593437A (en) | Use of the association of ivabradine and perindopril in the treatment of heart failure | |
| GEP20135970B (en) | New method of synthesis of ivabradine and pharmaceutically acceptable acid-additive salts thereof | |
| SI1614687T1 (sl) | Nov postopek za sintezo derivatov 1,3,4,5-tetrahidro-2h-3-benzazepin-2-ona in njihova uporaba za sintezo ivabradina kot tudi njegovih adicijskih soli s farmacevtsko sprejemljivo kislino | |
| AR058575A1 (es) | Asociacion de un inhibidor de la corriente sinusal if y de un inhibidor calcico y las composiciones farmaceuticas que la contienen | |
| CL2012003136A1 (es) | Procedimiento de sintesis de 3-{3-[{[(7s)-3,4-dimetoxibiciclo[4.2.0]octa-1,3,5-trien-7-il]metil}(metil)amino]propil}-7,8-dimetoxi-1,3,4,5-tetrahidro-2h-3-benzazepin-2-ona (ivabradina). | |
| GEP20156235B (en) | Process for enzymatic synthesis of (7s)-3,4-dimethoxy-bicyclo-[4.2.0]octa-1,3,5-triene-7- carboxylic acid or esters thereof, and application in synthesis of ivabradine and salts thereof | |
| CY1112037T1 (el) | Ιβαβραδινη και η χρηση της σε διαγνωστικη μεθοδο η οποια χρησιμοποιει την μεθοδο αγγειογραφιας των στεφανιαιων με τομοπυκνομετρια πολλαπλων τομων | |
| CU20090186A7 (es) | Composición inyectable de ivabradina | |
| TH137164A (th) | การใช้ประโยชน์จากการร่วมกันของสารยับยั้งกระแสไซนัสโหนด If (sinus node If current inhibitor) และสารยับยั้งเอนไซม์ซึ่งเปลี่ยนผันแองจิโอเทนซิน (angiotensin-converting enzyme inhibitor) ในการบำบัดภาวะหัวใจล้มเหลว | |
| TH93948A (th) | ไดฟีนิลอะซีทิดิโนนซึ่งถูกเข้าแทนที่ด้วยกรดพิเพอราซีน-1-ซัลโฟนิค ชนิดใหม่ และมีคุณสมบัติทางเภสัชวิทยาที่ดีขึ้น | |
| TH107683A (th) | กระบวนการใหม่สำหรับการสังเคราะห์อิวาเบรดีนและเกลือการเติมของสารนี้พร้อมด้วยกรดที่ยอมรับได้โดยทางเภสัชภัณฑ์ | |
| TH99437A (th) | สารร่วมสมทบชนิดใหม่ของสารยับยั้งกระแสต่อมไซนัส If และ สารยับยั้งเอนไซม์แปลงเปลี่ยน-แอนไจโอเทนซินและองค์ประกอบในทางเภสัชกรรมที่มีสารนั้น | |
| TH125503A (th) | การใช้ของไอวาบราดีนในฐานะสารที่เกี่ยวกับการวินิจฉัยโรคในวิธีการของโคโรนารี แองจิโอกราฟฟี โดยมัลติสไลซ์ คอมพิวเทด โทโมกราฟฟี | |
| TH70645A (th) | สารประกอบฟิวสด์ เฮเทอโรแอโรแมทิคชนิดใหม่ในฐานะตัวยับยั้งแฟคเตอร์การเจริญเติบโตของการแปลง (tgf) | |
| TH93948B (th) | ไดฟีนิลอะซีทิติโนนซึ่งถูกเข้าแทนที่ด้วยกรดพิเพอราซีน-1-ซัลโฟนิค ชนิดใหม่ และมีคุณสมบัติทางเภสัชวิทยาที่ดีขึ้น | |
| TH108769A (th) | N-(2-ไฮดรอกซิเอธิล)-n-เมธิล-4-(คลิโนลิน-8-อิล(1-ไธอะโซล-4-อิลเมธิล)พิเพอริดิน-4-อิลิดีน)เมธิล)เบนซาไมด์ |
Legal Events
| Date | Code | Title | Description |
|---|---|---|---|
| FA | Abandonment or withdrawal |